Reduction of vein graft disease using photodynamic therapy with motexafin lutetium in a rodent isograft model

Circulation

Volumn 102, Issue 19, 2000, Pages

  Yamaguchi, Atsushi ^a   Woodburn, Kathryn W ^b   Hayase, Motoya ^a   Robbins, Robert C ^a,c  

^a STANFORD UNIVERSITY   (United States)

^b PHARMACYCLICS INC   (United States)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Angioplasty; Bypass; Coronary disease; Grafting; Lasers

Indexed keywords

LU TEX; LUTETIUM; LUTETIUM TEXAPHYRIN; PHOTOSENSITIZING AGENT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERY INTIMA PROLIFERATION; ARTICLE; CELL ORGANELLE; CONTROLLED STUDY; CYTOTOXICITY; HUMAN; HUMAN CELL; ISOGRAFT; LAPAROTOMY; LASER ANGIOPLASTY; MACROPHAGE; MALE; MONONUCLEAR CELL; NONHUMAN; PHOTOACTIVATION; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; RAT; SMOOTH MUSCLE FIBER; VEIN DISEASE; VEIN GRAFT;

EID: 0034619386     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.cir.102.suppl_3.iii-275     Document Type: Article

References (25)

1. Results of biterminal transplantation of veins
2. Coronary bypass graft fate and patient outcome: Angiographic follow-up of 5065 grafts related to survival and reoperation in 1388 patients during 25 years
3. A multicenter, randomized trial of coronary angioplasty versus directional atherectomy for patients with saphenous vein bypass graft lesions
4. Immediate results and late outcomes after stem implantation in saphenous vein graft lesions: The multicenter US Palmaz-Schatz stent experience
5. Clinical success, complications and restenosis rates with excimer laser coronary angioplasty: The Percutaneous Excimer Laser Coronary Angioplasty Registry
6. Photodynamic therapy
7. Lutetium texaphyrin (PCI-0123): A near-infrared, water-soluble photosensitizer
8. Photodynamic therapy trials with lutetium texaphyrin (Lu-Tex) in patients with locally recurrent breast cancer
9. Phototherapy of cancer and atheromatous plaque with texaphyrins
10. Photoangioplasty: An emerging clinical cardiovascular role for photodynamic therapy
11. Use of tetrazolinm based colorimetric assay in assessing photoradiation therapy in vitro
12. Photodynamic therapy of B16F10 melanoma with lutetium texaphyrin
13. Pathologic changes in coronary artery saphenous vein grafts and related etiologic factors
14. Changes in saphenous veins used as aortocoronary bypass grafts
15. Status of the grafts and the native coronary arteries proximal and distal to coronary anastomotic sites of aortocoronary bypass grafts
16. Cytokinetic study of aortocoronary bypass vein grafts in place for less than six months
17. Determinants of the apoptotic response to lysosomal photodamage
18. Photodynamic therapy of vein grafts: Suppression of intimal hyperplasia of the vein graft but not the anastomosis
19. Inhibitory effect of methylene blue-induced photooxidation on intimal thickening of vein graft
20. Macrovascular and microvascular endothelium during long-term hypoxia: Alterations in cell growth, monolayer permeability, and cell surface coagulant properties
21. Oxygen tension regulates the expression of angiogenesis factor by macrophages
22. Hypoxia-mediated induction of acidic/basic fibroblast growth factor and platelet-derived growth factor in mononuclear phagocytes stimulates growth of hypoxic endothelial cells
23. Reduction of atheroma by photoangioplasty using intravascular delivery of antrin photosenstizer in an animal model
24. Macrophage infiltration predicts restenosis after coronary intervention in patients with unstable angina
25. Atherosclerosis: An inflammatory disease